
AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Fluor, you really have to buy into the idea that its value comes from converting a very large, mostly reimbursable project pipeline into steadier earnings, while keeping execution missteps under control. The limited notice to proceed for LNG Canada Phase 2 fits that story neatly: it reinforces long-term visibility in liquefied natural gas just as backlog has risen to US$25.70 billion and quarterly awards hit US$2.70 billion, mostly on lower-risk contract structures. In the near term, though, the LNG Canada news is more about option value than immediate financial impact, since it depends on a future final investment decision. Short-term catalysts still hinge more on how Fluor manages existing lump-sum problem projects, legal exposures and the new leadership team’s ability to sustain the Q1 2026 earnings recovery and buyback pace.
However, one operational issue in mining is an example of the risks investors should understand. Fluor's shares are on the way up, but could they be overextended? Uncover how much higher they are than fair value.Explore 9 other fair value estimates on Fluor - why the stock might be worth as much as 41% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com